Inhibitory effects of amino-acid fluids on drug binding to site II of human serum albumin in vitro

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 3, 2005, Pages 549-552

  Yamasaki, Keishi ^a   Kuga, Noriyuki ^b   Takamura, Norito ^c   Furuya, Yumiko ^a   Hidaka, Muneaki ^a   Iwakiri, Tomomi ^a   Nishii, Ryuuichi ^b   Okumura, Manabu ^a   Kodama, Hirofumi ^a   Kawai, Keiichi ^d   Arimori, Kazuhiko ^a  

^a UNIVERSITY OF MIYAZAKI HOSPITAL   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c KYUSHU UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^d KANAZAWA UNIVERSITY   (Japan)

Author keywords

Albumin; Amino acid; Binding site; Drug interaction; Parenteral nutrition; Protein binding

Indexed keywords

AMINO ACID; AMINOFLUID; AMINOLEBAN; AMINOTRIPA; AMIPAREN; DANSYLSARCOSINE; DIAZEPAM; FULCALIQ; HUMAN SERUM ALBUMIN; KIDMIN; PARENTERAL SOLUTION; PN TWIN; PROTEAMIN 12 X INJECTION; SARCOSINE; TRYPTOPHAN; UNCLASSIFIED DRUG; WARFARIN;

ARTICLE; BINDING SITE; CONTROLLED STUDY; DRUG BINDING; DRUG PROTEIN BINDING; FLUORESCENCE; HUMAN; IN VITRO STUDY; LIGAND BINDING; PARENTERAL NUTRITION; ULTRAFILTRATION;

ADULT; AMINO ACIDS; BINDING SITES; HUMANS; MALE; PARENTERAL NUTRITION; PHARMACEUTICAL PREPARATIONS; RECEPTORS, DRUG; SERUM ALBUMIN;

EID: 21144454808     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.549     Document Type: Article

References (37)

1. Peters T., Jr., "All about Albumin: Biochemistry, Genetics, and Medical Applications," Academic Press, San Diego, 1996.
2. Kragh-Hansen U., Chuang V. T., Otagiri M., Biol. Pharm. Bull., 25, 695-704 (2002).
3. Carter D. C., Ho J. X., Adv. Protein Chem., 45, 153-201 (1994).
4. Sellers E. M., Koch-Weser J., "Albumin Structure, Function and Uses," ed. by Rosenoer V. M., Oratz M., Rothschild M. A., Pergamon Press, Oxford, 1977, pp. 159-182.
5. Vallner J. J., J. Pharm. Sci., 66, 447-465 (1977).
6. McMenamy R. P., "Albumin Structure, Function and Uses," ed. by Rosenoer V. M., Oratz M., Rothschild M. A., Pergamon Press, Oxford, 1977, pp. 143-158.
7. Sudlow G., Birkett D. J., Wade D. N., Mol. Pharmacol., 11, 824-832 (1975).
8. Sudlow G., Birkett D. J., Wade D. N., Mol. Pharmacol., 12, 1052-1061 (1976).
9. Sjöholm I., Ekman B., Kober A., Ljungstedt-Pahlman I., Seiving B., Sjödin T., Mol. Pharmacol., 16, 767-777 (1979).
10. He X. M., Carter D. C., Nature (London), 358, 209-215 (1992).
11. Petitpas I., Bhattacharya A. A., Twine S., East M., Curry S., J. Biol. Chem., 276, 22804-22809 (2001).
12. Bos O. J., Remijn J. P., Fischer M. J., Wilting J., Janssen L. H., Biochem. Pharmacol., 37, 3905-3909 (1988).
13. Bos O. J., Fischer M. J., Wilting J., Janssen L. H., Biochem. Pharmacol., 38, 1979-1984 (1989).
14. Dockal M., Carter D. C., Ruker F., J. Biol. Chem., 274, 29303-29310 (1999).
15. Dockal M., Chang M., Carter D. C., Ruker F., Protein Sci., 9, 1455-1465 (2000).
16. Wilmore D. W., Dudrick S. J., JAMA, 203, 860-864 (1968).
17. Murphy A., Scott A., Hosp. Pharm., 7, 146-154 (2000).
18. ASPEN Board of Directors and The Clinical Guidelines Task Force, JPEN, 26, 1SA-138SA (2002).
19. Worthington P., Gilbert K. A., Wagner B. A., AACN Clin. Issues., 11, 559-579 (2000).
20. National Advisory Group on Standards of Practice Guidelines for Parenteral Nutrition, JPEN, 22, 49-66 (1998).
21. Walter-Sack I., de Vries J. X., Rudi J., Conradi R., Kohlmeier M., Kohl B., Weber E., Eur. J. Clin. Pharmacol., 42, 71-75 (1992).
22. Sangrador G., Sanchez-Alcaraz A., Ubeda R., Ibanez P., J. Clin. Pharm. Ther., 15, 273-278 (1990).
23. Pantuck E. J., Weissman C., Pantuck C. B., Lee Y. J., Anesth. Analg., 69, 727-731 (1989).
24. Burgess P., Hall R. I., Bateman D. N., Johnston I. D., JPEN, 11, 540-543 (1987).
25. Bailey D. N., Briggs J. R., Ther. Drug Monit., 26, 31-34 (2004).
26. Lackowicz J. R., "Principles of Fluorescence Spectroscopy," Plenum Press, New York, 1983.
27. Yamasaki K., Maruyama T., Kragh-Hansen U., Otagiri M., Biochim. Biophys. Acta, 1295, 147-157 (1996).
28. Yamasaki K., Maruyama T., Yoshimoto K., Tsutsumi Y., Narazaki R., Fukuhara A., Kragh-Hansen U., Otagiri M., Biochim. Biophys. Acta, 1432, 313-323 (1999).
29. Yacobi A., Udall J. A., Levy G., Clin. Pharmacol. Ther., 19, 552-558 (1976).
30. Piroli R. J., Passananti G. T., Shively C. A., Vesell E. S., Clin. Pharmacol. Ther., 30, 810-816 (1981).
31. Martyn J. A., Abernethy D. R., Greenblatt D. J., Clin. Pharmacol. Ther., 35, 535-539 (1984).
32. Grossman S. H., Davis D., Kitchell B. B., Shand D. G., Routledge P. A., Clin. Pharmacol. Ther., 31, 350-357 (1982).
33. Hage D. S., J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 768, 3-30 (2002).
34. Yang J., Hage D. S., J. Chromatogr. A, 725, 273-285 (1996).
35. Sollenne N. P., Wu H. L., Means G. E., Arch. Biochem. Biophys., 207, 264-269 (1981).
36. Kragh-Hansen U., Biochem. J., 209, 135-142 (1983).
37. Berard M. P., Hankard R., Cynober L., Clin. Nutr., 20, 407-414 (2001).